ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Sanofi at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Sanofi brings 5 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 4207. Its program centres on rheumatoid arthritis and related immune mechanisms, including an oral TNFR1 inhibitor, CD19 CAR T cells generated inside the body, the role of IL-6 across polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis, and knee osteoarthritis injection safety.

OrganizationACR Convergence 2026 Attendance
Sanofi
Cambridge, MA
Pharmaceutical companies
Global biopharmaceutical company developing medicines and vaccines.
Booth
Exhibiting at Booth 4207
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Mon Nov 9
3:30pm–4:15pm
Shared Immunopathology in PMR, GCA, and RA: The Central Role of IL-6
Innovation Theater B
Vasculitis · Rheumatoid arthritis · with Cleveland Clinic, Cabrillo Center for Rheumatic Disease

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Sanofi

Tell us what you sell and we’ll find the people at Sanofi most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction